Effectiveness of Oral Semaglutide in Management of Type 2 Diabetes: A Real-World Study from India

Effectiveness of Oral Semaglutide in Management of Type 2 Diabetes: A Real-World Study from India

Introduction: Oral Semaglutide (Sema-o) is the first oral glucagon like peptide-1 receptor analogue (GLP-1RA) commercially available for the treatment of type 2 diabetes (T2D). This study aimed to evaluate the efficacy of Sema-o in patients with T2D when added to the existing therapy. Methods: This...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aditya Dutta, Shama Mahendru, Rutuja Sharma, Ambrish Mithal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	hba1c oral semaglutide type 2 diabetes weight loss
Online Access:	https://journals.lww.com/10.4103/ijem.ijem_266_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study
by: Louis Talay, et al.
Published: (2024-10-01)

Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes
by: Michela Del Prete, et al.
Published: (2025-01-01)

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study
by: Hiroya Kitsunai, et al.
Published: (2025-01-01)

Semaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy
by: Fernando K. Malerbi, et al.
Published: (2025-01-01)

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01)

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)

Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
by: Jelena Petković-Dabić, et al.
Published: (2025-01-01)

Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
by: Srikanth Krishnan, et al.
Published: (2025-01-01)

Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
by: Jakob Grauslund, et al.
Published: (2024-12-01)

Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
by: Elisa Dinoi, et al.
Published: (2025-02-01)

A patient choice‐driven lifestyle intervention lowers HbA1c in type 2 diabetes: A feasibility study
by: Nathan R. Weeldreyer, et al.
Published: (2025-01-01)

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
by: Andrijana Koceva, et al.
Published: (2025-01-01)

Effects of Melatonin on Some Antioxidant Enzymes in Streptozotocin-induced Diabetic Rats
by: Ercan Keskin, et al.
Published: (2019-09-01)

The Impact of Time-Restricted Eating and Intermittent Fasting on Glycemia, Body Weight, and Overall Well-Being in Patients with Type 2 Diabetes – A Review of Studies
by: Szymon Przemysław Stolarczyk, et al.
Published: (2025-02-01)

Estimation of Undiagnosed Diabetes and Pre-diabetes in People 45–75 Years in Two Blocks of Himachal Pradesh, India: A Cross-sectional Study
by: Ashok Bhardwaj, et al.
Published: (2024-12-01)

Correlation Between Serum Uric Acid, Insulin and Hba1c In Type 2 Diabetes Mellitus
by: Maryam Imtiaz, et al.
Published: (2024-06-01)

Intermittent Use of Flash Glucose Monitoring Improves Glycemic Control in Chinese Older Patients with Type 2 Diabetes Mellitus
by: Hu Y, et al.
Published: (2025-01-01)

Association between maternal gestation weight gain and preterm birth according to pre-pregnancy body mass index and HbA1c
by: Xiaoxiao Zhang, et al.
Published: (2024-12-01)

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)
by: Sho Furusawa, et al.
Published: (2024-06-01)

Is HbA1c Predictive for Screening and Diagnosis of Gestational Diabetes Mellitus?
by: Neslihan Yerebasmaz, et al.
Published: (2014-08-01)

Association between hemoglobin glycation index and poor outcome after endovascular thrombectomy in acute ischemic stroke
by: Yan Yang, et al.
Published: (2025-02-01)

The Impact of Spirulina Supplementation on Iraqi Obese Females: A Cohort Study
by: Abdullah Salim Al-Karawi, et al.
Published: (2024-12-01)

Effect of social media-based education on self-care status, health literacy, and glycated hemoglobin in patients with type 2 diabetes
by: Ali Safdari, et al.
Published: (2025-01-01)

Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
by: Elton Mukonda, et al.
Published: (2025-01-01)

The Relationship Between Uric Acid/HDL Ratio and Monocyte/HDL Ratio and Glycemic Control in Male Type 2 Diabetic Patients
by: Semra Özkan Öztürk, et al.
Published: (2024-04-01)

Liraglutide Effect on Weight and A1C in Patients with Type 2 Diabetes Mellitus: Real-World Data from a Single Tertiary Care Center in Saudi Arabia
by: Awadh AlRashidi, et al.
Published: (2024-12-01)

Cross‐sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes
by: Mika Shimizu, et al.
Published: (2025-02-01)

Impact of Order Restrictions on Hemoglobin A1c Requests at Primary Health Care Centers in Riyadh, Saudi Arabia
by: Alakeely M, et al.
Published: (2025-01-01)

Systemic Predictors of Diabetic Retinopathy and Diabetic Macular Edema in an Adult Veteran Population
by: Tran EM, et al.
Published: (2025-01-01)

Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome
by: Ali M. Kadim Al-Tuma, et al.
Published: (2024-10-01)

A Study of Some Biochemical Parameters in COVID-19 Patients with Diabetes Mellitus: Comparative Study
by: Asmaa Sattar Abd, et al.
Published: (2022-11-01)

The Word become Flesh. Wild orality and “palliative” conservation for the Mexican performative arts
by: Juan Gerardo Ugalde Salinas
Published: (2024-10-01)

Potential benefits of GLP-1 analogues and metformin in patients with osteoarthritis
by: Anna Skowronek, et al.
Published: (2025-01-01)

Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity
by: Kenji Hara, et al.
Published: (2024-01-01)

Preoperative hemoglobin A1c is associated with postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy
by: Saori Motoda, et al.
Published: (2024-10-01)

Diyabetli Hastalarda Diyabetik Periferal Nöropati ile İlişkili Faktörlerin Değerlendirilmesi
by: Ali Akın
Published: (2024-12-01)

Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice
by: Marwa Al‐Badri, et al.
Published: (2025-01-01)

The rise in incidence of pediatric type 2 diabetes during the COVID-19 pandemic and the virus as a potential causative factor
by: Andrew Kanouse, et al.
Published: (2025-04-01)

Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes
by: Eijiro Yamada, et al.
Published: (2023-12-01)

Waist circumference and altered metabolic indices are associated with increased resting pulse rate in middle-aged adults
by: Laith Ashour, et al.
Published: (2025-01-01)